Page last updated: 2024-08-24

25-hydroxycholesterol and Pneumonia, Viral

25-hydroxycholesterol has been researched along with Pneumonia, Viral in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Q; Cheng, G; Deng, YQ; Gold, S; He, J; Li, J; Li, L; Li, X; Li, XF; Qin, CF; Yang, H; Zhang, C; Zhao, H; Zhou, C; Zu, S1

Other Studies

1 other study(ies) available for 25-hydroxycholesterol and Pneumonia, Viral

ArticleYear
25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor.
    Cell research, 2020, Volume: 30, Issue:11

    Topics: Aged; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Disease Models, Animal; Fatal Outcome; Female; Humans; Hydroxycholesterols; Mice; Mice, Inbred BALB C; Mice, Transgenic; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Virus Replication

2020